Evidence map›Paper›PMID 16254012›Full record

ArticleThe Journal of physiology2006

Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique.

Géza Berecki, Jan G Zegers, Zahurul A Bhuiyan, Arie O Verkerk, Ronald Wilders, Antoni C G van Ginneken

Abstract read
In one paragraph

Article in The Journal of physiology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Biophysical mechanisms of myocardium sodium channelopathies.Pflugers Archiv : European journal of physiology · 2024
    Review
  2. Article
  3. Article
  4. Dynamic action potential clamp predicts functional separation in mild familial and severe de novo forms ofProceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  5. Dysfunctional Nav1.5 channels due to SCN5A mutations.Experimental biology and medicine (Maywood, N.J.) · 2018
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. The effect of ranolazine on the vasodilator-induced myocardial perfusion abnormality.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2011
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Géza BereckiExperimental and Molecular Cardiology Group, Academic Medical Center, University of Amsterdam, The Netherlands. g.berecki@amc.uva.nl
Jan G Zegers
Zahurul A Bhuiyan
Arie O Verkerk
Ronald Wilders
Antoni C G van Ginneken

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long-QT3 syndrome (LQT3) is linked to cardiac sodium channel gene (SCN5A) mutations. In this study, we used the 'dynamic action potential clamp' (dAPC) technique to effectively replace the native sodium current (I(Na)) of the Priebe-Beuckelmann human ventricular cell model with wild-type (WT) or mutant I(Na) generated in a human embryonic kidney (HEK)-293 cell that is voltage clamped by the free-running action potential of the ventricular cell. We recorded I(Na) from HEK cells expressing either WT or LQT3-associated Y1795C or A1330P SCN5A at 35 degrees C, and let this current generate and shape the action potential (AP) of subepicardial, mid-myocardial and subendocardial model cells. The HEK cell's endogenous background current was completely removed by a real-time digital subtraction procedure. With WT I(Na), AP duration (APD) was longer than with the original Priebe-Beuckelmann model I(Na), due to a late I(Na) component of approximately 30 pA that could not be revealed with conventional voltage-clamp protocols. With mutant I(Na), this late component was larger ( approximately 100 pA), producing a marked increase in APD ( approximately 70-80 ms at 1 Hz for the subepicardial model cell). The late I(Na) magnitude showed reverse frequency dependence, resulting in a significantly steeper APD-frequency relation in the mutant case. AP prolongation was more pronounced for the mid-myocardial cell type, resulting in increased APD dispersion for each of the mutants. For both mutants, a 2 s pause following rapid (2 Hz) pacing resulted in distorted AP morphology and beat-to-beat fluctuations of I(Na). Our dAPC data directly demonstrate the arrhythmogenic nature of LQT3-associated SCN5A mutations.

Indexed as

Action PotentialsMutationPatch-Clamp TechniquesArrhythmias, CardiacCell LineElectrophysiologyHeart VentriclesHumansKidneyLong QT SyndromeModels, BiologicalNAV1.5 Voltage-Gated Sodium ChannelSodium ChannelsTime FactorsTransfectionVentricular FunctionNAV1.5 Voltage-Gated Sodium ChannelSCN5A protein, humanSodium Channels

Identifiers

PMID16254012
PMCPMC1464302

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.